Related Experiment Video
Updated: Jul 12, 2026
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Benefit-cost analysis in public health
1Graduate School of Industrial Administration, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA.
Annual Review of Public Health
|January 1, 1996
Summary
Benefit-cost analysis (BCA) and related tools evaluate public health interventions. Understanding their proper use and limitations is crucial to avoid misinterpretation by professionals.
Area of Science:
- Public Health
- Health Economics
- Policy Evaluation
Background:
- Benefit-cost analysis (BCA) and similar tools are increasingly used in public health decision-making.
- These economic evaluation methods provide frameworks for assessing the value of health interventions.
- Understanding these tools is essential for effective resource allocation in public health.
Purpose of the Study:
- To provide a comprehensive overview of benefit-cost analysis (BCA) and related evaluation tools in public health.
- To describe the application, limitations, and interpretation of these economic evaluation methods.
- To highlight the potential for misuse and misinterpretation of these powerful analytical tools.
Main Methods:
- Literature review of economic evaluation tools in public health.
- Descriptive analysis of benefit-cost analysis (BCA), cost-effectiveness analysis, and technology-based standards.
- Discussion of the practical application and interpretation challenges of these methods.
Main Results:
- Benefit-cost analysis (BCA), cost-effectiveness analysis, and technology-based standards are valuable but complex evaluation tools.
- These methods require careful application and interpretation to ensure accurate assessment of public health interventions.
- Potential for misuse and misinterpretation exists, even among professionals.
Conclusions:
- Effective utilization of economic evaluation tools in public health necessitates a thorough understanding of their methodologies and limitations.
- Proper interpretation of benefit-cost analysis (BCA) and related tools is vital for evidence-based public health policy.
- Continuous education and critical appraisal are recommended for professionals using these evaluation frameworks.
More Related Videos
Related Concept Videos
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:30Primary Healthcare Services
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:19Overview of Biostatistics in Health Sciences
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...